Wetenschappelijke publicaties van Erasme

Wetenschappelijke publicaties van Erasme

  • Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome.

  • Auteurs Virgilio E, Tielens S, Bonfield G, Nian FS, Sawatani T, Vinci C, Govier M, Montaser H, Lartigue R, Arunagiri A, Liboz A, Natividade da Silva F, Lytrivi M, Papadopoulou T, Wakeling MN, Russ-Silsby J, Bowman P, Johnson MB, Laver TW, Piron A, Yi X, Fantuzzi F, Hendrickx S, Igoillo-Esteve M, Santacreu BJ, Suntharesan J, Ghildiyal R, Hegde DG, Shah NA, Acar S, Özkaya Dönmez B, Özkan B, Mohsin F, Talaat IM, Abbas MT, Abbas OS, Alghamdi HA, Kandemir N, Flanagan SE, Scharfmann R, Arvan P, Raoux M, Nguyen L, Hattersley AT, Cnop M, De Franco E
  • Revue J Clin Invest
  • Date de publication 2025-09
Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome.
  • Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.

  • Auteurs Mathieu C, Wych J, Hendriks AEJ, Van Ryckeghem L, Tree T, Chmura P, Möller C, Casteels K, Danne T, Reschke F, Šmigoc Schweiger D, Battelino T, Johannesen J, Rami-Merhar B, Pieber T, De Block C, Evans M, Hilbrands R, Bosi E, Willemsen RH, Basu S, Pulkkinen MA, Knip M, Cnop M, Nitsche A, Schulte AM, Niemöller E, Peakman M, Wilhelm-Benartzi C, Gillespie D, Overbergh L, Mander AP, Marcovecchio ML
  • Revue Lancet
  • Date de publication 2025-09
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.
  • Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients.

  • Auteurs Sibilia B, Gonçalves T, Chevillon F, Zhao LP, Benayoun M, Baudet M, Toupin S, Dhedin N, Boissel N, Singh M, Unger A, Sicre de Fontbrune F, Michonneau D, Xhaard A, Peffault de Latour R, Logeart D, Cohen Solal A, Azibani F, Dillinger JG, Henry P, Robin M, Pezel T
  • Revue Eur J Prev Cardiol
  • Date de publication 2025-09
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients.
  • Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative - Update 2025.

  • Auteurs Areia M, Esposito G, Leclercq P, Romańczyk M, Zessner-Spitzenberg J, Delgado Guillena PG, Monged A, Honrubia López R, Uchima H, Ruiz Ballesteros EJ, Panarese A, Reis de Oliveira LA, Afify S, Bisschops R, Ferlitsch M
  • Revue Endoscopy
  • Date de publication 2025-09
Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative - Update 2025.
  • RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.

  • Auteurs Van Vooren E, Van Den Broeck F, Mahieu Q, Geens E, Van Heetvelde M, De Bruyne M, Van de Sompele S, Uppal S, Poliakov E, Dhaenens CM, Gregory-Evans CY, Hoefsloot L, Gonzalez AI, Kohl S, Zuleger T, Demaret T, Tuupanen S, Ruys J, Van Os L, Platteau E, Jacob J, Vermeer S, Postelmans L, Dahan K, Maystadt I, Rasquin F, Thiadens AAHJ, Stephenson KAJ, Sheri N, Smirnov V, MacDonald IM, Gregory-Evans K, Redmond TM, De Zaeytijd J, Leroy BP, Bauwens M, De Baere E
  • Revue Invest Ophthalmol Vis Sci
  • Date de publication 2025-09
RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals.
Huderf hospital

Queen Fabiola Kinderziekenhuis

Bekijk alle wetenschappelijke publicaties van het Koningin Fabiola Kinderziekenhuis

Bordet hospital

Jules Bordet-instituut

Bekijk alle wetenschappelijke publicaties van Jules Bordet

Decorative image of doctor and patient

Alle wetenschappelijke publicaties van het H.U.B.

Bekijk alle wetenschappelijke publicaties van het H.U.B.